CFTR and cystic fibrosis: While the efficiency of this strategy on CF caused by stop-codon mutation of the CFTR gene should be verified, this approach is expected to give appreciable results in CF cells carrying mutations impairing the processing or stability of the CFTR protein, supporting an interesting strategy for personalized therapy in precision medicine.